MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Embolization: A Closer Look
By Christoph A. Binkert, MD, FCIRSE, FSIR, and Charles E. Ray Jr, MD, PhD, MS
cTACE: The Rebirth of Lipiodol?
Lipiodol-based cTACE remains the most well-studied transarterial therapy for hepatocellular carcinoma.
By Ali Kord Valeshabad, MD, MPH; Jeffrey Kuwahara, MD; and Charles E. Ray Jr, MD, PhD, MS
ATTRACT 2-Year Data and Commentary
Two-year ATTRACT data show that anticoagulation alone is best for most deep vein thrombosis; pharmacomechanical catheter-directed thrombolysis benefits seen in certain iliofemoral patients.
SIR Recommends Changes to CMS's Proposed New Payment Rules
June 28, 2016—The Society of Interventional Radiology (SIR) announced that it has submitted comments to the Centers for Medicare & Medicaid Services (CMS) recommending changes to the Quality Payment Program proposed rule. On April 27, the US Department of Health and Human Services announced that it was issuing a Notice of Proposed Rulemaking to implement key provisions of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), bipartisan legislation that replaced the flawed Sustainable Growth Rate formula with a new approach to paying clinicians for the value and quality of care they provide.
SIR Publishes Study on Patient Follow-Up After IVC Filter Placement
November 28, 2011—The Society of Interventional Radiology (SIR) announced the publication of the largest single-institution patient population study to date analyzing a method for following patients with retrievable inferior vena cava (IVC) filters.
Interventional Radiology Registry Launched by SIR and ACR
March 1, 2017—The Society of Interventional Radiology (SIR) and the American College of Radiology (ACR) announced the initiation of the Interventional Radiology (IR) Registry.
2-Year ATTRACT Data: Anticoagulation Alone Best for Most DVT; PCDT Benefits Seen in Certain Iliofemoral Patients
March 6, 2017—The much-anticipated 2-year results from the ATTRACT study were presented by Suresh Vedantham, MD, FSIR, on behalf of the trial’s investigators, at the 2017 Society of Interventional Radiology (SIR) Annual Scientific Meeting.
